Pharmaceutical Executive
London, UK-Insurance companies will be unable to use genetic test results to approve or deny claims for at least the next five years, following a new agreement between the British government and the Association of British Insurers. The move ensures that people can still get insurance coverage whether or not they have had a test.
London, UK-Insurance companies will be unable to use genetic test results to approve or deny claims for at least the next five years, following a new agreement between the British government and the Association of British Insurers. The move ensures that people can still get insurance coverage whether or not they have had a test.
During the next five years, the government will work with the insurance industry to develop a long-term policy. For now, the rules apply to life policies of up to £500,000 and long-term care insurance and income protection of up to £300,000.
Health minister Lord Philip Hunt says, "I recognize that there is public anxiety around the use of genetic test results and insurance, and I welcome this five-year breathing space to work with the industry to get things right. However, if there is evidence of serious and persistent noncompliance by the insurance industry, then the government is prepared to enforce the moratorium, through legislation, if necessary."
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.